Make the FDA small again

FDA regulation doesn’t just inconvenience Americans – it puts their lives at risk Back in January, President Donald Trump vowed to cut the Food and Drug Administration’s (FDA) regulations by 75-80 percent, a dramatic policy shift from his predecessor who oversaw regulatory costs skyrocket to more than $100 billion annually. […]

FDA is Trying to Snuff Out America’s Cigar Industry

New rule would cripple a $20 billion industry and put thousands of American jobs in danger Washington, D.C. – Cause of Action Institute (“CoA Institute”) today filed an amicus curiae brief in support of Plaintiffs the Cigar Association of America, the International Premium Cigar and Pipe Retailers Association, and Cigar […]

CoA Institute Investigates Red Tape Limiting Access to Zika Testing

Washington D.C. – Cause of Action Institute (“CoA Institute”) today sent a Freedom of Information Act (“FOIA”) request to the Food and Drug Administration (“FDA”) to examine its role in regulating laboratory developed tests (“LDTs”), including tests for the Zika virus. This investigation comes on the heels of the FDA’s […]

Amber Abbasi: The Curious Case of Trent Arsenault: Questioning FDA Regulatory Authority Over Private Sperm Donation

Amber Abbasi, chief counsel for regulatory affairs at Cause of Action, wrote an article for the Annals of Health Law, the Health Policy and Law Review of Loyola University of Chicago School of Law:   The Curious Case of Trent Arsenault: Questioning FDA Regulatory Authority Over Private Sperm Donation  

CoA Joins Coalition of Government Accountability Advocates in Asking FDA to Revise FOIA Policy

Earlier this week, Cause of Action was proud to join a number of other transparency organizations in sending a letter to the FDA concerning their FOIA deletions policy. Read more below from Open the Government and follow this link to see the letter.   Groups to FDA: Make FOIA Process […]

Doe v. Hamburg Amended Complaint and Exhibits

Amended complaint in Doe v. Hamburg et al. case filed on January 11th, 2013 in the US District Court for the Northern District of California. Amended Complaint Exhibit 1 Exhibit 2    

Amber Abbasi: Questioning FDA Regulation of Private Sperm Donation, speech at Columbia Law School

Video: Questioning FDA Regulation of Private Sperm Donation